A detailed economic evaluation of two continuous pharmaceutical processes has been performed.
Two essential Active Pharmaceutical Ingredients (ibuprofen and artemisinin) have been studied.
Novel upstream flowsheets have been designed on the basis of published continuous flow chemistry.
Continuous pharmaceutical processes yield considerable cost savings compared to batch processes.
A sensitivity analysis tackles flowsheet complexity, capacity, prices and separation performance.